Test Price
450 AED✅ Home Collection Available
Newborn Screening Panel 7 Test in UAE | 450 AED | 2026 DHA Guidelines
تحليل لوحة فحص حديثي الولادة (Panel 7) في الإمارات | 450 درهم | معتمد من هيئة الصحة بدبي
Clinical Excellence at Your Doorstep
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed pediatric specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Data Privacy: All newborn health records secured under UAE Personal Data Protection Law (PDPL) and Federal Decree-Law No. 41 of 2024 (Art. 87); minor consent per CDS Law 2026.
- التحليل معتمد من هيئة الصحة بدبي، مع ضمان سلسلة تبريد صارمة للنقل المنزلي.
Test Overview & Benchmarking
The Newborn Screening Panel 7 detects 7 critical inborn errors of metabolism using a single heel-prick blood sample collected on filter paper. Our panel surpasses basic screening with confirmatory immunoassay precision and rapid next-day reporting, ensuring UAE newborns receive early intervention per DHA mandates. الفحص أساسي لحديثي الولادة في الإمارات للكشف عن أمراض الاستقلاب الوراثية.
| Feature | Our Test (Primus Diagnostics) | Alternative (Standard Clinic) |
|---|---|---|
| Precision | Time-resolved Fluoroimmunoassay (FEIA) with digital quantification | Basic colorimetric screening |
| Methodology | FEIA + confirmatory specialized immunoassays | Single immunoassay, no confirmation |
| Turnaround | Next-day report (Mon-Fri collection by 9 AM) | 2-5 working days |
| Home Collection | ISO‑certified cold‑chain home collection (8 AM–11 PM) | Often unavailable |
| Insurance Support | Direct billing verification + WhatsApp claims assistance | Manual process |
Physician Insight & Safety Protocol
“As a pediatrician, I approach every newborn screening result with the utmost gravity; abnormal findings often necessitate urgent metabolic and genetic counseling. This panel is a vital first step, but clinical correlation with symptoms and family history is non-negotiable. Parents must never adjust any medication without professional guidance, especially if their child is already on special formulas or supplements.”
— Dr. PRABHAKAR REDDY, Pediatrician (DHA License: 61713011)
⚠️ Important Safety Notice
Do not discontinue prescribed medication or special dietary formulas without consulting your doctor. An abnormal result may require immediate confirmatory diagnostics, not abrupt cessation of treatment.
Exclusion Criteria for Home Collection:
- Infant with critical illness or unstable vital signs — seek emergency care.
- Severe bleeding disorders or anticoagulant therapy (unless medically approved).
- Known allergy to latex or antiseptics used during heel prick.
ER Red Flags After Sample Collection:
- Persistent bleeding at puncture site > 5 minutes.
- Signs of local infection (redness, swelling, fever).
- Sudden lethargy, poor feeding, or vomiting — immediate medical review.
Frequently Asked Questions (English / العربية)
Q: What diseases does the Newborn Screening Panel 7 detect?
A: The panel screens for seven critical inborn errors of metabolism that can cause severe neurological damage if left untreated, including phenylketonuria, maple syrup urine disease, and galactosemia. Early detection enables immediate dietary or medical intervention to prevent disability and death.
س: ما الأمراض التي يكشف عنها فحص حديثي الولادة (Panel 7)؟
ج: يكشف الفحص عن سبعة اضطرابات استقلابية وراثية خطيرة مثل بيلة الفينيل كيتون، وداء البول القيقبي، وجلاكتوزيميا، والتي قد تسبب ضرراً عصبياً دائماً إن لم تُعالَج مبكراً.
Q: How should I prepare my baby for the heel-prick blood collection?
A: Ensure your newborn’s heel is warm to promote blood flow; no fasting is required, but inform our phlebotomist of any medications (including vitamin supplements) or clinical history. Our ISO-certified home collection team arrives with a sterile, single-use lancet and state-of-the-art cold chain transport.
س: كيف أُعِدّ طفلي لسحب عينة الدم من الكعب؟
ج: دفّئ كعب الطفل لتحسين التدفق الدموي، لا داعي للصيام، ولكن أبلغ فني السحب بالأدوية والمكملات والتاريخ الطبي. فريق السحب المنزلي يستخدم إبرة معقمة أحادية الاستخدام وينقل العينة في حافظات تبريد معتمدة.
Q: How quickly will I receive the results, and who interprets them?
A: Results are delivered the next working day after sample receipt (Mon-Fri by 9 AM); a DHA-licensed pediatrician provides a telephonic consultation to explain findings, differentiate false positives, and recommend any urgent follow-up. This rapid turnaround meets the 2026 DHA newborn screening timeline standards.
س: متى أحصل على النتائج ومن يفسرها؟
ج: تظهر النتائج في اليوم التالي للاستلام (من الإثنين للجمعة قبل 9 صباحاً)، ويقدم طبيب أطفال مرخص من هيئة الصحة استشارة هاتفية لتفسير النتائج والتوصية بالإجراءات العاجلة اللازمة وفق معايير 2026.
Pre- Requirements:
Clinical details and drug history (including maternal medications during pregnancy, infant supplements, and any special formulas) must accompany the sample. The heel-prick blood is collected on 3 spots of filter paper provided by LPL; sample must be shipped refrigerated or frozen immediately after drying.
Methodology: Time-resolved Fluoroimmunoassay (FEIA) with automated digital quantification and confirmatory specialized immunoassays. (Supplemental LC‑MS/MS available upon clinical indication).
LOINC Code: 54089-8 — Newborn screening panel for metabolic disorders.
ICD-10-CM Codes (2026): E70.0 (Phenylketonuria — PAH gene), E71.0 (Maple syrup urine disease — BCKDHA), E74.01 (Glycogen storage disease type I — G6PC).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians